Chai Discovery nabs $400M Series C as AI-designed antibodies reach Big Pharma

Chai Discovery Inc., a company that develops artificial intelligence models to predict interactions between biochemical molecules, today announced it has raised $400 million in Series C funding, nearly tripling its valuation to $3.8 billion. Index Ventures led the round alongside Kleiner Perkins, Sequoia Capital and Dimension. New investors joining the investment included Bain Capital Ventures, […] The post Chai Discovery nabs $400M Series C as AI-designed antibodies reach Big Pharma appeared fi